Jérôme Bombal

Jérôme Bombal serves as the Quality Director and Deleguate QP at EG LABO - STADA GROUP since March 2011, overseeing a team of 10 professionals responsible for a diverse product portfolio of approximately 900 items, including RX, OTX, OTC, medical devices, and biosimilars. Their role encompasses managing the global quality system, coordinating launches, conducting product quality reviews, overseeing audit planning and execution, and handling various quality-related processes such as deviation management, risk assessments, and market releases of around 3000 batches annually. Prior to this, Jérôme held the position of Interim Responsible Pharmacist at Debiopharm from January 2003 to February 2011, leading a team focused on regulatory submissions and batch releases for clinical trials, alongside GMP audits of manufacturing sites. Jérôme holds a Doctorate in Pharmacy from Université Paris Cité and a postgraduate degree in Pharmacovigilance from the same institution.